Co-Authors
This is a "connection" page, showing publications co-authored by Gary McAuliffe and Shivani Fox-Lewis.
Connection Strength
1.956
-
A comparison of SARS-CoV-2 antibody assays evaluated in Auckland, New Zealand. N Z Med J. 2020 11 20; 133(1525):127-131.
Score: 0.914
-
Lack of N2-gene amplification on the Cepheid Xpert Xpress SARS-CoV-2 assay and potential novel causative mutations: A case series from Auckland, New Zealand. IDCases. 2021; 25:e01233.
Score: 0.240
-
SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study. Pathology. 2021 Jun; 53(4):530-535.
Score: 0.234
-
Evaluation of extraction and amplification assays for the detection of SARS-CoV-2 at Auckland Hospital laboratory during the COVID-19 outbreak in New Zealand. J Virol Methods. 2021 03; 289:114042.
Score: 0.230
-
An understanding of discordant SARS-CoV-2 test results: an examination of the data from a central Auckland laboratory. N Z Med J. 2020 07 31; 133(1519):81-88.
Score: 0.224
-
Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand. Clin Transl Immunology. 2021; 10(3):e1261.
Score: 0.058
-
Age-related differences in SARS-CoV-2 testing in the Northern Region of New Zealand. N Z Med J. 2020 07 31; 133(1519):89-94.
Score: 0.056